Industry Medical technology Products Medical devices Headquarters Singapore | Founded unknown Website www.biosensors.com Type of business Public (SGX: B20) | |
 | ||
Key people Lu Yoh-Chie, Chairman and founding CEO; Mike Kleine, CEO Revenue USD $37.8 Million (2006) | ||
Europcr 2016 industry partner biosensors international group ltd
Biosensors International Group is a medical device company that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The company was listed in the Mainboard of the Singapore Exchange (SGX) in May 2005. The global headquarters of the company are located in Singapore, where the main manufacturing facilities and R&D centers are hosted. The European headquarters are in Morges, Switzerland; this Swiss office is also the Legal Manufacturer of BioMatrix, the current leading product of the company.
Contents
- Europcr 2016 industry partner biosensors international group ltd
- Biomatrix neoflex biosensors international ltd
- References
BioMatrix is a drug-eluting stent that utilizes proprietary technologies of Biosensors:
Biosensors has obtained CE Mark for this drug-eluting stent product in January 2008.
To enter the China market, Biosensors has set up a joint-venture with Hong Kong listed Shandong Weigao to market and distribute coronary stents in China.
As one of the few companies with proprietary drug-eluting stent technology, Biosensors also has been obtaining revenue through licensing its technologies to other medical device companies like Terumo, and specialty-stent providers like Devax, Inc. and Xtent, Inc.